CJE HEALTH EXAM NEWEST 2026/2027 ACTUAL
EXAM TEST BANK | WOMEN'S HEALTH CJE
EXAM QUESTIONS AND CORRECT DETAILED
ANSWERS A+ GRADED /GUARANTEED PASS!!|
QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES 2026
Q&A | INSTANT DOWNLOAD PDF
Core Domains
1. Reproductive Anatomy and Physiology
2. Prenatal, Intrapartum, and Postpartum Care
3. Gynecological Health and Disorders
4. Family Planning and Contraception
5. Menstrual and Menopausal Health
6. High-Risk Pregnancy and Obstetric Emergencies
7. Ethics, Legal Issues, and Professional Standards in Women's Health
8. Health Promotion, Disease Prevention, and Patient Education
9. Pharmacology and Pain Management in Women's Health
10. Psychosocial and Cultural Aspects of Women's Health
Introduction
This comprehensive examination is designed to rigorously assess the candidate's
foundational knowledge, critical thinking skills, and clinical decision-making
abilities in the specialized field of women's health. The test covers a broad
spectrum of topics, from core reproductive anatomy and physiology to complex
high-risk obstetrics, ethical dilemmas, and professional standards. Through a
combination of multiple-choice questions and scenario-based applications, the
exam emphasizes the practical application of evidence-based care. Candidates are
expected to demonstrate proficiency in health promotion, disease prevention,
patient education, and the management of common and complex conditions,
ensuring they are prepared to deliver safe, competent, and compassionate care in a
variety of healthcare settings.
,SECTION ONE: QUESTIONS 1-100
Question 1
A 32-year-old woman at 28 weeks gestation presents with a sudden onset of severe,
generalized abdominal pain and vaginal bleeding. Her uterus is firm and tender to
palpation. What is the most likely diagnosis?
A. Placenta previa
B. Ruptured ovarian cyst
C. Preterm labor
D. Abruptio placentae
D. Abruptio placentae
RATIONALE: The classic presentation of abruptio placentae includes sudden,
severe abdominal pain, a tense and tender uterus, and vaginal bleeding in the third
trimester. Placenta previa typically presents with painless bleeding. Preterm labor
involves regular contractions and cervical changes. A ruptured ovarian cyst is less
likely to present with uterine tenderness and firmness.
Question 2
A 25-year-old woman is prescribed an oral contraceptive pill. She asks about the
primary mechanism of action. What is the correct response?
A. Thickening of cervical mucus and altering endometrial lining
B. Preventing fertilization by blocking the fallopian tubes
C. Inducing a permanent state of anovulation
D. Enhancing the immune response to sperm
A. Thickening of cervical mucus and altering endometrial lining
RATIONALE: Combined oral contraceptives primarily work by suppressing
ovulation through inhibition of gonadotropins. They also thicken cervical mucus to
impede sperm penetration and alter the endometrial lining to prevent implantation.
They do not block fallopian tubes or induce permanent anovulation.
,Question 3
A 68-year-old woman is evaluated for postmenopausal bleeding. She has a history
of hypertension and diabetes. What is the most critical initial step in her
management?
A. Prescribing antibiotics for a suspected infection
B. Performing a pelvic ultrasound
C. Reassuring the patient and scheduling a follow-up in 6 months
D. Starting a course of hormone replacement therapy
B. Performing a pelvic ultrasound
RATIONALE: Postmenopausal bleeding is a cardinal sign of endometrial
cancer. A pelvic ultrasound, specifically a transvaginal ultrasound to measure
endometrial stripe thickness, is the initial, non-invasive diagnostic step to evaluate
for endometrial pathology. Antibiotics, reassurance, or hormone therapy are not
appropriate without a proper diagnostic evaluation.
Question 4
During a routine prenatal visit, a 23-year-old G1P0 woman at 12 weeks gestation
asks about the purpose of the first-trimester screen. What is the best explanation?
A. To evaluate the fetus for structural anomalies such as spina bifida
B. To assess the risk of fetal aneuploidies like Down syndrome
C. To determine the fetal blood type and Rh factor
D. To check for maternal diabetes and preeclampsia risk
B. To assess the risk of fetal aneuploidies like Down syndrome
RATIONALE: The first-trimester screening, which includes a maternal serum
marker test (PAPP-A, beta-hCG) and a nuchal translucency ultrasound, is designed
to assess the risk of fetal aneuploidies, such as Down syndrome (Trisomy 21) and
Trisomy 18. It does not evaluate for structural anomalies like spina bifida (which is
typically done in the second trimester), determine fetal blood type, or screen for
maternal complications like diabetes or preeclampsia.
Question 5
A 45-year-old woman reports significant vasomotor symptoms, including hot
, flashes and night sweats, and is interested in non-hormonal management options.
Which of the following is a recommended non-hormonal therapy for menopausal
symptoms?
A. Low-dose oral estrogen
B. Vaginal estrogen cream
C. Selective serotonin reuptake inhibitors (SSRIs)
D. Progestin-only pills
C. Selective serotonin reuptake inhibitors (SSRIs)
RATIONALE: SSRIs and SNRIs (like paroxetine, venlafaxine) are effective
non-hormonal options for managing vasomotor symptoms. Low-dose oral
estrogen, vaginal estrogen cream, and progestin-only pills are hormonal treatments.
Paroxetine is the only non-hormonal medication FDA-approved for this indication,
but others are used off-label.
Question 6
A nurse is educating a 19-year-old female about the human papillomavirus (HPV)
vaccine. The patient asks about the purpose of the vaccine. What is the most
accurate response?
A. It provides 100% protection against all sexually transmitted infections.
B. It prevents cervical cancer and genital warts by protecting against certain high-
risk and low-risk HPV types.
C. It is a treatment for patients already infected with HPV.
D. It is only effective if administered after a patient becomes sexually active.
B. It prevents cervical cancer and genital warts by protecting against certain
high-risk and low-risk HPV types.
RATIONALE: The HPV vaccine is prophylactic and protects against the most
common high-risk (cancer-causing) and low-risk (wart-causing) HPV types. It does
not protect against all STIs and is not a treatment for existing HPV infections. It is
most effective when administered before the onset of sexual activity.
Question 7
A 29-year-old G2P1 woman at 39 weeks gestation is in active labor. Her cervix is 6
EXAM TEST BANK | WOMEN'S HEALTH CJE
EXAM QUESTIONS AND CORRECT DETAILED
ANSWERS A+ GRADED /GUARANTEED PASS!!|
QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES 2026
Q&A | INSTANT DOWNLOAD PDF
Core Domains
1. Reproductive Anatomy and Physiology
2. Prenatal, Intrapartum, and Postpartum Care
3. Gynecological Health and Disorders
4. Family Planning and Contraception
5. Menstrual and Menopausal Health
6. High-Risk Pregnancy and Obstetric Emergencies
7. Ethics, Legal Issues, and Professional Standards in Women's Health
8. Health Promotion, Disease Prevention, and Patient Education
9. Pharmacology and Pain Management in Women's Health
10. Psychosocial and Cultural Aspects of Women's Health
Introduction
This comprehensive examination is designed to rigorously assess the candidate's
foundational knowledge, critical thinking skills, and clinical decision-making
abilities in the specialized field of women's health. The test covers a broad
spectrum of topics, from core reproductive anatomy and physiology to complex
high-risk obstetrics, ethical dilemmas, and professional standards. Through a
combination of multiple-choice questions and scenario-based applications, the
exam emphasizes the practical application of evidence-based care. Candidates are
expected to demonstrate proficiency in health promotion, disease prevention,
patient education, and the management of common and complex conditions,
ensuring they are prepared to deliver safe, competent, and compassionate care in a
variety of healthcare settings.
,SECTION ONE: QUESTIONS 1-100
Question 1
A 32-year-old woman at 28 weeks gestation presents with a sudden onset of severe,
generalized abdominal pain and vaginal bleeding. Her uterus is firm and tender to
palpation. What is the most likely diagnosis?
A. Placenta previa
B. Ruptured ovarian cyst
C. Preterm labor
D. Abruptio placentae
D. Abruptio placentae
RATIONALE: The classic presentation of abruptio placentae includes sudden,
severe abdominal pain, a tense and tender uterus, and vaginal bleeding in the third
trimester. Placenta previa typically presents with painless bleeding. Preterm labor
involves regular contractions and cervical changes. A ruptured ovarian cyst is less
likely to present with uterine tenderness and firmness.
Question 2
A 25-year-old woman is prescribed an oral contraceptive pill. She asks about the
primary mechanism of action. What is the correct response?
A. Thickening of cervical mucus and altering endometrial lining
B. Preventing fertilization by blocking the fallopian tubes
C. Inducing a permanent state of anovulation
D. Enhancing the immune response to sperm
A. Thickening of cervical mucus and altering endometrial lining
RATIONALE: Combined oral contraceptives primarily work by suppressing
ovulation through inhibition of gonadotropins. They also thicken cervical mucus to
impede sperm penetration and alter the endometrial lining to prevent implantation.
They do not block fallopian tubes or induce permanent anovulation.
,Question 3
A 68-year-old woman is evaluated for postmenopausal bleeding. She has a history
of hypertension and diabetes. What is the most critical initial step in her
management?
A. Prescribing antibiotics for a suspected infection
B. Performing a pelvic ultrasound
C. Reassuring the patient and scheduling a follow-up in 6 months
D. Starting a course of hormone replacement therapy
B. Performing a pelvic ultrasound
RATIONALE: Postmenopausal bleeding is a cardinal sign of endometrial
cancer. A pelvic ultrasound, specifically a transvaginal ultrasound to measure
endometrial stripe thickness, is the initial, non-invasive diagnostic step to evaluate
for endometrial pathology. Antibiotics, reassurance, or hormone therapy are not
appropriate without a proper diagnostic evaluation.
Question 4
During a routine prenatal visit, a 23-year-old G1P0 woman at 12 weeks gestation
asks about the purpose of the first-trimester screen. What is the best explanation?
A. To evaluate the fetus for structural anomalies such as spina bifida
B. To assess the risk of fetal aneuploidies like Down syndrome
C. To determine the fetal blood type and Rh factor
D. To check for maternal diabetes and preeclampsia risk
B. To assess the risk of fetal aneuploidies like Down syndrome
RATIONALE: The first-trimester screening, which includes a maternal serum
marker test (PAPP-A, beta-hCG) and a nuchal translucency ultrasound, is designed
to assess the risk of fetal aneuploidies, such as Down syndrome (Trisomy 21) and
Trisomy 18. It does not evaluate for structural anomalies like spina bifida (which is
typically done in the second trimester), determine fetal blood type, or screen for
maternal complications like diabetes or preeclampsia.
Question 5
A 45-year-old woman reports significant vasomotor symptoms, including hot
, flashes and night sweats, and is interested in non-hormonal management options.
Which of the following is a recommended non-hormonal therapy for menopausal
symptoms?
A. Low-dose oral estrogen
B. Vaginal estrogen cream
C. Selective serotonin reuptake inhibitors (SSRIs)
D. Progestin-only pills
C. Selective serotonin reuptake inhibitors (SSRIs)
RATIONALE: SSRIs and SNRIs (like paroxetine, venlafaxine) are effective
non-hormonal options for managing vasomotor symptoms. Low-dose oral
estrogen, vaginal estrogen cream, and progestin-only pills are hormonal treatments.
Paroxetine is the only non-hormonal medication FDA-approved for this indication,
but others are used off-label.
Question 6
A nurse is educating a 19-year-old female about the human papillomavirus (HPV)
vaccine. The patient asks about the purpose of the vaccine. What is the most
accurate response?
A. It provides 100% protection against all sexually transmitted infections.
B. It prevents cervical cancer and genital warts by protecting against certain high-
risk and low-risk HPV types.
C. It is a treatment for patients already infected with HPV.
D. It is only effective if administered after a patient becomes sexually active.
B. It prevents cervical cancer and genital warts by protecting against certain
high-risk and low-risk HPV types.
RATIONALE: The HPV vaccine is prophylactic and protects against the most
common high-risk (cancer-causing) and low-risk (wart-causing) HPV types. It does
not protect against all STIs and is not a treatment for existing HPV infections. It is
most effective when administered before the onset of sexual activity.
Question 7
A 29-year-old G2P1 woman at 39 weeks gestation is in active labor. Her cervix is 6
